$CMRX
CHIMERIX INC

2020 Q2 Form 10-Q Financial Statement

#000111748020000028 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $1.402M $1.438M
YoY Change -2.5% 20.54%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.110M $4.400M
YoY Change -29.32% -33.83%
% of Gross Profit
Research & Development $8.578M $13.83M
YoY Change -37.96% 0.84%
% of Gross Profit
Depreciation & Amortization $110.0K $160.0K
YoY Change -31.25% -33.33%
% of Gross Profit
Operating Expenses $11.69M $20.14M
YoY Change -41.96% -1.1%
Operating Profit -$10.29M -$18.70M
YoY Change -45.0% -2.44%
Interest Expense $270.0K $1.070M
YoY Change -74.77% 69.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$10.02M -$17.65M
YoY Change -43.23% -5.16%
Income Tax
% Of Pretax Income
Net Earnings -$10.02M -$17.65M
YoY Change -43.25% -5.17%
Net Earnings / Revenue -714.41% -1227.4%
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$0.16 -$345.2K
COMMON SHARES
Basic Shares Outstanding 62.04M shares 51.07M shares
Diluted Shares Outstanding 62.04M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.00M $158.4M
YoY Change -39.39% -9.38%
Cash & Equivalents $53.50M $21.64M
Short-Term Investments $42.40M $136.8M
Other Short-Term Assets $2.600M $2.200M
YoY Change 18.18% -33.33%
Inventory
Prepaid Expenses
Receivables $367.0K $774.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $98.90M $161.4M
YoY Change -38.72% -9.5%
LONG-TERM ASSETS
Property, Plant & Equipment $338.0K $1.054M
YoY Change -67.93% -29.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.00K $45.00K
YoY Change -42.22% -13.46%
Total Long-Term Assets $2.778M $2.068M
YoY Change 34.33% -90.88%
TOTAL ASSETS
Total Short-Term Assets $98.90M $161.4M
Total Long-Term Assets $2.778M $2.068M
Total Assets $101.7M $163.4M
YoY Change -37.79% -18.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.425M $1.832M
YoY Change -22.22% 28.47%
Accrued Expenses $4.811M $11.95M
YoY Change -59.75% 49.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.236M $13.79M
YoY Change -54.77% 46.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.300M $500.0K
YoY Change 360.0% 150.0%
Total Long-Term Liabilities $2.300M $500.0K
YoY Change 360.0% 150.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.236M $13.79M
Total Long-Term Liabilities $2.300M $500.0K
Total Liabilities $8.538M $14.32M
YoY Change -40.39% 49.4%
SHAREHOLDERS EQUITY
Retained Earnings -$689.3M -$591.6M
YoY Change 16.51% 12.64%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $93.14M $149.1M
YoY Change
Total Liabilities & Shareholders Equity $101.7M $163.4M
YoY Change -37.79% -18.68%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$10.02M -$17.65M
YoY Change -43.25% -5.17%
Depreciation, Depletion And Amortization $110.0K $160.0K
YoY Change -31.25% -33.33%
Cash From Operating Activities -$7.870M -$13.82M
YoY Change -43.05% -1.57%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$50.00K
YoY Change -100.0% -16.67%
Acquisitions
YoY Change
Other Investing Activities $36.25M $15.79M
YoY Change 129.58% -18.48%
Cash From Investing Activities $36.25M $15.74M
YoY Change 130.3% -18.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 580.0K 20.00K
YoY Change 2800.0% -60.0%
NET CHANGE
Cash From Operating Activities -7.870M -13.82M
Cash From Investing Activities 36.25M 15.74M
Cash From Financing Activities 580.0K 20.00K
Net Change In Cash 28.96M 1.940M
YoY Change 1392.78% -63.6%
FREE CASH FLOW
Cash From Operating Activities -$7.870M -$13.82M
Capital Expenditures $0.00 -$50.00K
Free Cash Flow -$7.870M -$13.77M
YoY Change -42.85% -1.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001117480
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2020Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35867
dei Entity Registrant Name
EntityRegistrantName
CHIMERIX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0903395
dei Entity Address Address Line1
EntityAddressAddressLine1
2505 Meridian Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Durham
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27713
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
806-1074
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2302000 USD
dei Trading Symbol
TradingSymbol
CMRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62187734 shares
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53501000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16901000 USD
CY2020Q2 us-gaap Debt Securities Current
DebtSecuritiesCurrent
42449000 USD
CY2019Q4 us-gaap Debt Securities Current
DebtSecuritiesCurrent
96574000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
367000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1233000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2578000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3385000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
196000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
98895000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
118093000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
338000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
540000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2414000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
709000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34000 USD
CY2020Q2 us-gaap Assets
Assets
101673000 USD
CY2019Q4 us-gaap Assets
Assets
119376000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1425000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2398000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4811000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6830000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6236000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9228000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
8538000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
9424000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2019Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62172418 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62172418 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61590013 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61590013 shares
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
62000 USD
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
62000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
782217000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
778693000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
130000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
35000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-689274000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-668838000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
93135000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
109952000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101673000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119376000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1402000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1438000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2643000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3794000 USD
CY2020Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
8578000 USD
CY2019Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
13827000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
17527000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27342000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3110000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6312000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6315000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13998000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
11688000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
20139000 USD
us-gaap Operating Expenses
OperatingExpenses
23842000 USD
us-gaap Operating Expenses
OperatingExpenses
41340000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10286000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18701000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-21199000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-37546000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
270000 USD
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1051000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
763000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2203000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10016000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-17650000 USD
us-gaap Net Income Loss
NetIncomeLoss
-20436000 USD
us-gaap Net Income Loss
NetIncomeLoss
-35343000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
141000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
77000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
95000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
217000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9875000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17573000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20341000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35126000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62042778 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51130104 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61892407 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51009935 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
109952000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1326000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
229000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-46000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-10420000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10466000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
101041000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1391000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
578000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
141000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-10016000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9875000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
93135000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
177604000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4073000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
170000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
140000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-17693000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17553000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
164307000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2367000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
77000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-17650000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17573000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
149118000 USD
us-gaap Net Income Loss
NetIncomeLoss
-20436000 USD
us-gaap Net Income Loss
NetIncomeLoss
-35343000 USD
us-gaap Depreciation
Depreciation
216000 USD
us-gaap Depreciation
Depreciation
306000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
277000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1205000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2717000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6440000 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
0 USD
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-30000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
-43000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
-36000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-866000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
444000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-809000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-399000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2546000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
302000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18694000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29551000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
150000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
27652000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
107149000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1498000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
80652000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
77210000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
54487000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30089000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
578000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
229000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
171000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
23000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
807000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
178000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36600000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-59462000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16901000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81106000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53501000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21644000 USD
cmrx Numberof Product Candidates
NumberofProductCandidates
2 product_candidate
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Reclassifications</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net income or stockholders' equity (deficit).</span></div>
CY2020Q2 cmrx Accrued Development Liabilities
AccruedDevelopmentLiabilities
1736000 USD
CY2019Q4 cmrx Accrued Development Liabilities
AccruedDevelopmentLiabilities
1868000 USD
CY2020Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
2271000 USD
CY2019Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
3626000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
804000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1336000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4811000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6830000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
42319000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
130000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
42449000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
96539000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
50000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
96574000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
22798000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
15000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
22798000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
15000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
9 security
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
9 security
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
42449000 USD
CY2020Q2 cmrx Debt Securities Available For Sale Fair Value Matuirty Allocated And Single Maturity Date Year Two
DebtSecuritiesAvailableForSaleFairValueMatuirtyAllocatedAndSingleMaturityDateYearTwo
0 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
42449000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M1D
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
173000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
182000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
366000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
376000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0828
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2414000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
189000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2302000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2491000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
362000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
191000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
546000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
562000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
580000 USD
CY2020Q2 cmrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
955000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3196000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
705000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2491000 USD
CY2020Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P65M
cmrx Lessee Operating Lease Rent Abatement Term
LesseeOperatingLeaseRentAbatementTerm
P5M
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
719000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
182000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
901000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
66000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
835000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
180000 USD
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
194000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
357000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
386000 USD
CY2020Q2 cmrx Lessee Operating Sublease Areaof Sublease Property
LesseeOperatingSubleaseAreaofSubleaseProperty
3537 sqft
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
18000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
18000 USD
us-gaap Sublease Income
SubleaseIncome
35000 USD
us-gaap Sublease Income
SubleaseIncome
35000 USD
CY2020Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
41000 USD
CY2020Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
14000 USD
CY2020Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
55000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
0 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
163000 shares
CY2019Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
201000 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
369000 shares
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1391000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2367000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2717000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6440000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2019Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
43 employee
CY2019 us-gaap Severance Costs1
SeveranceCosts1
3300000 USD
CY2019 us-gaap Business Exit Costs1
BusinessExitCosts1
2000000.0 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
320000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
320000 USD
CY2019 us-gaap Other Restructuring Costs
OtherRestructuringCosts
300000 USD
CY2019 cmrx Fixed Asset Disposals
FixedAssetDisposals
300000 USD
CY2019 us-gaap Business Exit Costs1
BusinessExitCosts1
2000000.0 USD
us-gaap Severance Costs1
SeveranceCosts1
3346000 USD
us-gaap Business Exit Costs1
BusinessExitCosts1
2021000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
339000 USD
cmrx Fixed Asset Disposals
FixedAssetDisposals
250000 USD
us-gaap Restructuring Charges
RestructuringCharges
5956000 USD
CY2018Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2019 cmrx Restructuring Reserve Accruals
RestructuringReserveAccruals
5781000 USD
CY2019 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-336000 USD
CY2019 us-gaap Payments For Restructuring
PaymentsForRestructuring
5125000 USD
CY2020Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-14000 USD
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
218000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
88000 USD
CY2020Q2 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-5000 USD
CY2020Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
69000 USD
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
14000 USD
CY2020Q2 cmrx Proceeds From Refund Of Deposits
ProceedsFromRefundOfDeposits
1300000 USD

Files In Submission

Name View Source Status
0001117480-20-000028-index-headers.html Edgar Link pending
0001117480-20-000028-index.html Edgar Link pending
0001117480-20-000028.txt Edgar Link pending
0001117480-20-000028-xbrl.zip Edgar Link pending
a20200630cmrxex-101.htm Edgar Link pending
a20200630cmrxex-102.htm Edgar Link pending
a20200630cmrxex-103.htm Edgar Link pending
a20200630cmrxex-104.htm Edgar Link pending
a20200630cmrxex-105.htm Edgar Link pending
a20200630cmrxex-11.htm Edgar Link pending
a20200630cmrxex-311.htm Edgar Link pending
a20200630cmrxex-312.htm Edgar Link pending
a20200630cmrxex-321.htm Edgar Link pending
a20200630cmrxex-322.htm Edgar Link pending
a20200630cmrxex-51.htm Edgar Link pending
cmrx-20200630.htm Edgar Link pending
cmrx-20200630.xsd Edgar Link pending
cmrx-20200630_cal.xml Edgar Link unprocessable
cmrx-20200630_def.xml Edgar Link unprocessable
cmrx-20200630_htm.xml Edgar Link completed
cmrx-20200630_lab.xml Edgar Link unprocessable
cmrx-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image111.jpg Edgar Link pending
image211.jpg Edgar Link pending
image311.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
suite1001.jpg Edgar Link pending
suite2501.jpg Edgar Link pending
suite300-3401.jpg Edgar Link pending